A peek at the latest miniaturization trends, including nano-robots that transport therapeutics to tumors.
Managing data, interoperability and cybersecurity issues were at the top of the list for industry stakeholders.
Mainstream media attention catapulted the company to the center of controversy for its finger-prick lab tests. Now FDA has taken issue with the company’s complaint handling and design validation.
Expect to see slow growth and more mergers & acquisitions.
Ernst & Young’s Pulse of the Industry report is out, and once again, it’s not all gloom and doom.
There is a great unmet need for pediatric-specific devices. Why aren’t more manufacturers addressing this critical area?
Regulations, cost pressures drive medical device companies to innovate.
The technology platform has already gone global and has the potential to be a true breakthrough in screening and detecting several types of cancer.
When entering this emerging market, the benefits may outweigh any risks.
After preparing for three key issues, follow these recommended strategies when pursuing the market in Japan.